Anti-OAS2 antibody (61-110 aa) (STJ96901)
SPECIFICATIONS
ClonalityPolyclonal
HostRabbit
ConjugationUnconjugated
IsotypeIgG
ImmunogenThe antiserum was produced against synthesized peptide derived from the N-terminal region of human OAS2 at the amino acid range 61-110
General Information
| Short Description | Rabbit polyclonal anti-2 5 oligoadenylate synthase 2oligoA synthase 2 (61-110 aa) for use in WB, IHC, IF and ELISA in Human, Rat and Mouse samples. Datasheet included with dilution recommendations, and related reagents. |
| Applications | WB/IHC/IF/ELISA |
| Host | Rabbit |
| Reactivity | Human/Rat/Mouse |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Clonality | Polyclonal |
| Isotype | IgG |
| Conjugation | Unconjugated |
| Concentration | 1 mg/mL |
| Purification | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Dilution Range | WB 1:500-1:2000IHC-P 1:100-1:300ELISA 1:20000IF 1:50-200 |
| Formulation | Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Storage Instruction | Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Target Information
| Gene Symbol | OAS2 |
| Gene ID | 4939 |
| Uniprot ID | OAS2_HUMAN |
| Immunogen | The antiserum was produced against synthesized peptide derived from the N-terminal region of human OAS2 at the amino acid range 61-110 |
| Immunogen Region | 61-110 aa |
| Specificity | OAS2 Polyclonal Antibody detects endogenous levels of OAS2 protein. |
Additional Info
| Function | Interferon-induced, dsRNA-activated antiviral enzyme which plays a critical role in cellular innate antiviral response. Activated by detection of double stranded RNA (dsRNA): polymerizes higher oligomers of 2'-5'-oligoadenylates (2-5A) from ATP which then bind to the inactive monomeric form of ribonuclease L (RNASEL) leading to its dimerization and subsequent activation. Activation of RNASEL leads to degradation of cellular as well as viral RNA, resulting in the inhibition of protein synthesis, thus terminating viral replication. Can mediate the antiviral effect via the classical RNASEL-dependent pathway or an alternative antiviral pathway independent of RNASEL. In addition, it may also play a role in other cellular processes such as apoptosis, cell growth, differentiation and gene regulation. May act as a negative regulator of lactation, stopping lactation in virally infected mammary gland lobules, thereby preventing transmission of viruses to neonates. Non-infected lobules would not be affected, allowing efficient pup feeding during infection. |
| Protein Name | 2'-5'-Oligoadenylate Synthase 2(2-5'Oligo(A Synthase 22-5a Synthase 2P69 Oas / P71 OasP69oas / P71oas |
| Database Links | Reactome: R-HSA-877300Reactome: R-HSA-8983711Reactome: R-HSA-909733Reactome: R-HSA-9833110 |
| Cellular Localisation | CytoplasmPerinuclear Region |
| Alternative Antibody Names | Anti-2'-5'-Oligoadenylate Synthase 2 antibodyAnti-(2-5'Oligo(A Synthase 2 antibodyAnti-2-5a Synthase 2 antibodyAnti-P69 Oas / P71 Oas antibodyAnti-P69oas / P71oas antibodyAnti-OAS2 antibody |
Information sourced from Uniprot.org